BSECompany Update5d ago · 14 Aug 2026, 04:01 pm
Statement of NIL deviation or variation for the quarter ended June 30, 2026
Shree Hari Chemicals Export Ltd · 524336
✦ AI SummaryResults
Shree Hari Chemicals Export Ltd has submitted a statement of NIL deviation or variation for the quarter ended June 30, 2026, as per Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shree Hari Chemicals Export Ltd - 524336 - Statement Of NIL Deviation(S) Or Variation(S) For The Quarter Ended June 30, 2026.
Attachments (1)
📄pdf
Download →
74e201e4-585a-4da1-9532-50cb206d1dc6.pdf
View document text
Date: August 14, 2026
The General Manager
DCS - CRD
BSE LIMITED
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai - 400 001
Scrip code: 524336
Dear Sir/Madam,
Sub: Statement of deviation(s) or variation(s) for the quarter ended June 30, 2026.
Ref.: Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“Listing Regulations”)
Pursuant to regulation 32 of the SEBI Listing Regulations, please note that there are no
deviation(s) or variation(s) in respect of the utilization of the proceeds of the Preferential Issue
of the Company during the quarter ended June 30, 2026.
Accordingly, a NIL statement of deviation or variation is enclosed herewith as ‘Annexure A’
You are requested to kindly take the same on record.
Please note further that the proceeds of the Preferential Issue have been fully utilized and
there has been no deviations in the use of proceeds from the objects as stated in the
explanatory statement to the notice for the Annual General Meeting held on September 27,
2024.
Thanking you.
Yours faithfully,
FOR SHREE HARI CHEMICALS EXPORT LIMITED
B.C. AGRAWAL
Chairman & Managing Director
DIN: 00121080
Annexure- A
Statement of Deviation / Variation in utilisation of funds raised
Name of listed entity SHREE HARI CHEMICALS EXPORT LIMITED
Mode of Fund Raising Initial Public Offer / Rights Issues / Preferential Issues /
QIP / Others
Date of Raising Funds November 12, 2024, November 13, 2024, March 05, 2025,
July 10, 2025 & July 11, 2025
Amount Raised Rs. 14,74,59,820/-
Report filed for Quarter ended June 30, 2026
Monitoring Agency Not Applicable
Monitoring Agency Name, if applicable Not Applicable
Is there a Deviation / Variation in use of Nil
funds raised
If yes, whether the same is pursuant to change Not Applicable
in terms of a contract or objects, which was
approved by the shareholders
If Yes, Date of shareholder Approval Not Applicable
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after None
review
Comments of the auditors, if any Not Applicable
Objects for which funds have been raised and Not Applicable
where there has been a deviation, in the
following table:
Original Object Modified Original Modified Funds Amount of Remarks
Object, if Allocation allocation, Utilised Deviation/Variation if any
any (₹ in Crore) if any (₹ in Crore) for the quarter
according to
applicable object
Not Applicable as no deviation from object.
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc.
Signature:
Name of Signatory BANKESH CHANDRA AGRAWAL
Designation Chairman & Managing Director